Home

Incannex Healthcare Limited

ASX Code

IHL

Sector

Pharmaceuticals- Biotechnology & Life Sciences

Investor Centre

https://incannex.com.au/investors/

Website

https://incannex.com.au/

About

Incannex Healthcare Limited (IHL.ASX) is an innovator and developer of medicinal cannabinoid pharmaceutical products with global export capability.

IHL is currently undertaking 4 significant clinical programs to develop 4 uniquely formulated products in its relentless pursuit of FDA registration and market exclusivity over the following indications:

• Obstructive Sleep Apnoea (‘OSA’)
• Traumatic Brain Injury (‘TBI’)/Concussion
• Sepsis Associated Acute Respiratory Distress Syndrome (‘SAARDS’)
• Temporomandibular Joint Disorder (‘TMJD’).IHL

News